Funder: National Institutes of Health

Due Dates: June 17, 2025 (New) | July 18, 2025 (Renewal/Resubmission/Revision) | October 20, 2025 (New) | November 18, 2025 (Renewal/Resubmission/Revision) | February 19, 2026 (New) | March 18, 2026 (Renewal/Resubmission/Revision) | June 18, 2026 (New) | July 20, 2026 (Renewal/Resubmission/Revision) | October 20, 2026 (New) | November 18, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 direct costs over 2–3 years; no more than $200,000 in any single year; max project period 3 years.

Summary: Supports exploratory or developmental research on the ethical, legal, and social implications (ELSI) of human genetics and genomics, with emphasis on new technologies and stakeholder engagement.

Key Information: Clinical trials are optional; foreign and domestic applicants eligible; strong data sharing and resource sharing plans required.